相关基金
- NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
- Health April 5, 2024 $1,000,000
- Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential
- Viruses 2024-04-11 €50000000
- Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators
- Translational medicine 2024-04-11 €2000000
- Bio-printing of living cells for regenerative medicine
- Digital Agenda 2024-04-11 €25000000
- Advanced battery system integration for next generation vehicles (2ZERO Partnership)
- Sustainable transport - general 2024-04-18 €10000000
- Australian National Aged Care Classification (AN-ACC) Transition Fund
- Aged Care 30-Jun-2024 $55,440,000.00
- European Partnership: One Health Anti-Microbial Resistance
- Antimicrobial resistance 2024-09-25 €100000000
- Strategic Prevention Framework – Partnerships for Success for States
- Health Jun 05, 2025 12:00:00 AM EDT $1,250,000
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
- Health Jun 06, 2025 12:00:00 AM EDT $295,924